IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 203 filers reported holding IMMUNOGEN INC in Q4 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $687,000 | +66.3% | 43,341 | +98.0% | 0.00% | – |
| Q2 2023 | $413,000 | +70.7% | 21,891 | -65.2% | 0.00% | – |
| Q1 2023 | $242,000 | -56.8% | 62,932 | -44.3% | 0.00% | – |
| Q4 2022 | $560,000 | -0.5% | 113,008 | -4.0% | 0.00% | – |
| Q3 2022 | $563,000 | +23.2% | 117,730 | +15.9% | 0.00% | – |
| Q2 2022 | $457,000 | -22.9% | 101,605 | -18.4% | 0.00% | – |
| Q1 2022 | $593,000 | -48.8% | 124,570 | -20.3% | 0.00% | – |
| Q4 2021 | $1,159,000 | +46.0% | 156,201 | +11.7% | 0.00% | – |
| Q3 2021 | $794,000 | -9.2% | 139,787 | +5.3% | 0.00% | – |
| Q2 2021 | $874,000 | -39.8% | 132,749 | -25.9% | 0.00% | – |
| Q1 2021 | $1,452,000 | +25.6% | 179,161 | +0.0% | 0.00% | – |
| Q4 2020 | $1,156,000 | +40.3% | 179,104 | -21.8% | 0.00% | – |
| Q3 2020 | $824,000 | -9.5% | 229,001 | +15.5% | 0.00% | – |
| Q2 2020 | $911,000 | +89.8% | 198,193 | +40.7% | 0.00% | – |
| Q1 2020 | $480,000 | -33.1% | 140,816 | +0.2% | 0.00% | – |
| Q4 2019 | $717,000 | +103.1% | 140,484 | -3.7% | 0.00% | – |
| Q3 2019 | $353,000 | +14.6% | 145,887 | +2.9% | 0.00% | – |
| Q2 2019 | $308,000 | -9.1% | 141,756 | +13.2% | 0.00% | – |
| Q1 2019 | $339,000 | -42.2% | 125,232 | +2.3% | 0.00% | – |
| Q4 2018 | $587,000 | -52.4% | 122,447 | -5.9% | 0.00% | -100.0% |
| Q3 2018 | $1,233,000 | +8.8% | 130,143 | +11.8% | 0.00% | 0.0% |
| Q2 2018 | $1,133,000 | -17.4% | 116,384 | -10.7% | 0.00% | 0.0% |
| Q1 2018 | $1,372,000 | -4.1% | 130,388 | -41.6% | 0.00% | 0.0% |
| Q4 2017 | $1,431,000 | +12.8% | 223,138 | +34.5% | 0.00% | 0.0% |
| Q3 2017 | $1,269,000 | +15.6% | 165,938 | +7.5% | 0.00% | 0.0% |
| Q2 2017 | $1,098,000 | +1514.7% | 154,432 | +789.0% | 0.00% | – |
| Q1 2017 | $68,000 | +74.4% | 17,371 | -11.5% | 0.00% | – |
| Q4 2016 | $39,000 | -13.3% | 19,624 | +17.0% | 0.00% | – |
| Q3 2016 | $45,000 | -27.4% | 16,776 | -15.1% | 0.00% | – |
| Q2 2016 | $62,000 | -62.9% | 19,760 | +0.5% | 0.00% | – |
| Q1 2016 | $167,000 | -55.6% | 19,658 | -29.1% | 0.00% | – |
| Q4 2015 | $376,000 | +46.9% | 27,737 | +3.8% | 0.00% | – |
| Q3 2015 | $256,000 | -24.5% | 26,716 | +13.3% | 0.00% | – |
| Q2 2015 | $339,000 | +62.2% | 23,585 | +1.1% | 0.00% | – |
| Q1 2015 | $209,000 | +20.1% | 23,336 | -18.0% | 0.00% | – |
| Q4 2014 | $174,000 | -8.4% | 28,470 | +58.3% | 0.00% | – |
| Q3 2014 | $190,000 | -53.4% | 17,989 | -47.8% | 0.00% | – |
| Q2 2014 | $408,000 | -0.2% | 34,444 | +25.7% | 0.00% | – |
| Q1 2014 | $409,000 | +23.6% | 27,404 | +21.5% | 0.00% | – |
| Q4 2013 | $331,000 | -32.0% | 22,549 | -21.3% | 0.00% | – |
| Q3 2013 | $487,000 | -8.5% | 28,658 | -10.8% | 0.00% | – |
| Q2 2013 | $532,000 | – | 32,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |